Eric L Grogan

15PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 24, 2026
TP53-mutated preneoplastic colonies, adaptive immune response, and risk for lung cancer and COPD.

|Jun 23, 2026
Longitudinal analysis of CYFRA 21-1 levels in patients with pulmonary nodules: Differential trajectories between benign and malignant cases.

|Jun 10, 2026
Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules.

|Jun 03, 2026
Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

|Feb 06, 2026
Longitudinal Analysis of CYFRA 21-1 Levels in Patients with Pulmonary Nodules: Differential Trajectories Between Benign and Malignant Cases and Impact of Tumor Resection.

Yency J Forero, Michael N Kammer, Kevin C McGann

|Sep 15, 2025
Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet?

Kevin C McGann, Timothy A Khalil, Michael N Kammer

Pageof 3

Frequent Collaborators

8 joint publications

Steve A Deppen

7 joint publications

Michael N Kammer

6 joint publications

Fabien Maldonado

3 joint publications

Bennett Landman